Dorothy J. Becker mainly focuses on Internal medicine, Diabetes mellitus, Type 1 diabetes, Endocrinology and Surgery. Many of her studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. In her research on the topic of Gastroenterology, Rituximab is strongly related with Area under the curve.
Her Diabetes mellitus research includes themes of Blood pressure, Epidemiology, Pediatrics and Cohort. Her research in Type 1 diabetes intersects with topics in Autoantibody, Randomized controlled trial, Nod and Immunology. Her work is dedicated to discovering how Endocrinology, Hemoglobin are connected with Body weight, Weight control, Diabetes treatment, Weight loss and Type ii diabetes and other disciplines.
Diabetes mellitus, Internal medicine, Endocrinology, Type 1 diabetes and Insulin are her primary areas of study. Her Diabetes mellitus research includes elements of Surgery, Epidemiology, Pediatrics and Cohort. Her Epidemiology study integrates concerns from other disciplines, such as Complication, Incidence and Disease, Microalbuminuria.
As part of one scientific family, Dorothy J. Becker deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Area under the curve. Dorothy J. Becker has included themes like Hemoglobin and Insulin dependent diabetes in her Endocrinology study. Her work carried out in the field of Type 1 diabetes brings together such families of science as Gerontology, Autoantibody, Randomized controlled trial, Immunology and Insulin resistance.
Her primary areas of study are Type 1 diabetes, Internal medicine, Diabetes mellitus, Autoantibody and Endocrinology. Her Type 1 diabetes research is multidisciplinary, relying on both C-peptide, Immunology, Breastfeeding, Pediatrics and Oral glucose tolerance. Her biological study spans a wide range of topics, including Gastroenterology and Type 2 diabetes.
Her research integrates issues of Young adult, Disease, Cohort study and Family medicine in her study of Diabetes mellitus. She interconnects Proportional hazards model, Autoimmunity and Insulin, Islet in the investigation of issues within Autoantibody. Her work in Endocrinology addresses subjects such as Cumulative incidence, which are connected to disciplines such as Nephropathy.
Dorothy J. Becker focuses on Type 1 diabetes, Diabetes mellitus, Internal medicine, Autoantibody and Cohort. Her Type 1 diabetes study incorporates themes from Developmental psychology, Breastfeeding, Randomized controlled trial and Glycemic. Her Diabetes mellitus research is multidisciplinary, incorporating perspectives in Area under the curve, Combination therapy, Pharmacology, Clinical trial and Disease.
Internal medicine and Endocrinology are commonly linked in her work. The various areas that Dorothy J. Becker examines in her Autoantibody study include Autoimmunity and Islet. The study incorporates disciplines such as Body mass index, Overweight, Cohort study, Insulin resistance and Risk factor in addition to Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker.
The New England Journal of Medicine (2009)
Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II
Trevor J Orchard;Janice S Dorman;Raelene E Maser;Dorothy J Becker.
Diabetes (1990)
Long-term effects of modest weight loss in type II diabetic patients.
Rena R. Wing;Randi Koeske;Leonard H. Epstein;Mary Patricia Nowalk.
JAMA Internal Medicine (1987)
Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study
Trevor J. Orchard;Jon C. Olson;John R. Erbey;Katherine Williams.
Diabetes Care (2003)
The 30-year natural history of type 1 diabetes complications : The pittsburgh epidemiology of diabetes complications study experience
Georgia Pambianco;Tina Costacou;Demetrius Ellis;Dorothy J. Becker.
Diabetes (2006)
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
Suna Onengut-Gumuscu;Wei-Min Chen;Oliver Burren;Nick J Cooper.
Nature Genetics (2015)
Can clinical factors estimate insulin resistance in type 1 diabetes
Katherine V. Williams;John R. Erbey;Dorothy Becker;Silva Arslanian.
Diabetes (2000)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio.
The Lancet (2011)
Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study
Raelene E Maser;Ann R Steenkiste;Janice S Dorman;Viggo Kamp Nielsen.
Diabetes (1989)
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio.
The Lancet (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
University of South Florida
Tampere University
Carnegie Mellon University
University of Helsinki
University of Florida
University of Minnesota
University of Washington
Rutgers, The State University of New Jersey
Columbia University
MIT
Zhejiang University
University of California, San Francisco
Goethe University Frankfurt
University of Queensland
Commonwealth Scientific and Industrial Research Organisation
Philipp University of Marburg
University of Antwerp
University of East Anglia
New Mexico Institute of Mining and Technology
University of Southern California
University of Arizona
Columbia University
York University